{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:54:57Z","timestamp":1759056897115},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.diabres.2008.12.003","type":"journal-article","created":{"date-parts":[[2009,1,15]],"date-time":"2009-01-15T09:32:51Z","timestamp":1232011971000},"page":"289-294","source":"Crossref","is-referenced-by-count":30,"title":["Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes"],"prefix":"10.1016","volume":"83","author":[{"given":"Scherezade","family":"Momin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara","family":"Angel B","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethel","family":"Codner D","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Carrasco P","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Perez-Bravo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2008.12.003_bib1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.diabres.2007.01.043","article-title":"Functional evaluation of the type 1 diabetes (T1D) susceptibility candidate genes","volume":"77S","author":"Park","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.diabres.2008.12.003_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2005.09.024","article-title":"Infections and autoimmune diseases","volume":"25","author":"Bach","year":"2005","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.diabres.2008.12.003_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cca.2007.09.021","article-title":"Genetic polymorphisms in susceptibility to type 1 diabetes","volume":"387","author":"Alizadeh","year":"2008","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.diabres.2008.12.003_bib4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1196\/annals.1288.071","article-title":"Dietary microbial toxins and type 1 diabetes","volume":"1005","author":"Myers","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.diabres.2008.12.003_bib5","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00125-002-0801-1","article-title":"A missing link in the hygiene hypothesis?","volume":"45","author":"Gale","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2008.12.003_bib6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.molmed.2005.12.005","article-title":"Genetic progress towards the molecular basis of autoimmunity","volume":"12","author":"Pearce","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.diabres.2008.12.003_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.diabres.2003.09.015","article-title":"Prevention of type 1 diabetes: from the view point of \u03b2 cell damage","volume":"66","author":"Kawasaki","year":"2004","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.diabres.2008.12.003_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.molmed.2008.04.002","article-title":"The molecular genetics of type 1 diabetes: new genes and emerging mechanism","volume":"14","author":"Ounissi-Benkalha","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.diabres.2008.12.003_bib9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev.immunol.21.120601.141036","article-title":"Molecular interactions mediating T cell antigen recognition","volume":"21","author":"van der Merwe","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.diabres.2008.12.003_bib10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/08916930500124072","article-title":"PD-1\/PD-L pathways and autoimmunity","volume":"38","author":"Okazaki","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.diabres.2008.12.003_bib11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.diabres.2008.12.003_bib12","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrg1944","article-title":"Genetics of autoimmune diseases\u2013disorders of immune homeostasis","volume":"7","author":"Gregersen","year":"2006","journal-title":"Nat. Rev."},{"key":"10.1016\/j.diabres.2008.12.003_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1443","article-title":"The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection","volume":"8","author":"Sharpe","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.diabres.2008.12.003_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1196\/annals.1375.043","article-title":"Molecular scanning of the gene for programmed cell death-1 (PDCD1) as a candidate for type diabetes susceptibility","volume":"1079","author":"Hiromine","year":"2006","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.diabres.2008.12.003_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20022125","article-title":"The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice","volume":"198","author":"Ansari","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.diabres.2008.12.003_bib16","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1084\/jem.20061577","article-title":"Insulin-induced remission in new-onset NOD mice is maintained by PD-1\u2013PD-L1 pathway","volume":"203","author":"Fife","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.diabres.2008.12.003_bib17","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/jcb.21677","article-title":"Molecular mechanisms of death ligand-mediated immune modulation: a gene therapy model to prolong islet survival in type 1 diabetes","volume":"104","author":"Sanlioglu","year":"2008","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.diabres.2008.12.003_bib18","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/ilar.45.3.278","article-title":"Rat models of type 1 diabetes: genetics, environment, and autoimmunity","volume":"45","author":"Mordes","year":"2004","journal-title":"ILAR J."},{"key":"10.1016\/j.diabres.2008.12.003_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev.immunol.24.021605.090535","article-title":"A molecular perspective of CTLA-4 function","volume":"24","author":"Teft","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.diabres.2008.12.003_bib20","first-page":"1121","article-title":"Prevalence of diabetes mellitus in a Mapuche community of Region IX, Chile","volume":"113","author":"Larenas","year":"1985","journal-title":"Rev. Med. Chile"},{"issue":"Suppl. l","key":"10.1016\/j.diabres.2008.12.003_bib21","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1016\/S0168-8227(96)90023-6","article-title":"One of the lowest validated incidence rates of insulin dependent diabetes mellitus in the Americas: Santiago, Chile","volume":"34","author":"Carrasco","year":"1996","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.diabres.2008.12.003_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/dmrr.558","article-title":"Increasing incidence of type 1 diabetes in population from Santiago of Chile: trends in a period of 18 years (1986\u20132003)","volume":"22","author":"Carrasco","year":"2006","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.diabres.2008.12.003_bib23","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2337\/diabetes.52.5.1128","article-title":"Diabetes Antibody Standardization Program: first assay proficiency evaluation","volume":"52","author":"Bingley","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2008.12.003_bib24","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature01621","article-title":"Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease","volume":"423","author":"Ueda","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.diabres.2008.12.003_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1740-2557-2-8","article-title":"Lack of correlation between the levels of soluble cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and the CT-60 genotypes","volume":"2","author":"Purohit","year":"2005","journal-title":"J. Autoimmune Dis."},{"key":"10.1016\/j.diabres.2008.12.003_bib26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00439-004-1172-0","article-title":"Role of an intronic polymorphism in the PDCD1 gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphospholipid antibodies","volume":"115","author":"Sanghera","year":"2004","journal-title":"Hum. Genet."},{"key":"10.1016\/j.diabres.2008.12.003_bib27","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1002\/art.20436","article-title":"Association of PDCD1 with susceptibility to systemic lupus erythematosus","volume":"50","author":"Ferreiros-Vidal","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.diabres.2008.12.003_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.gene.6364370","article-title":"Bias in association studies of systemic lupus erythematosus susceptibility due to geographical variation in the frequency of a programmed cell death 1 polymorphism across Europe","volume":"8","author":"Ferreiros-Vidal","year":"2007","journal-title":"Genes Immunol."},{"key":"10.1016\/j.diabres.2008.12.003_bib29","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/art.20280","article-title":"Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope","volume":"50","author":"Prokunina","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.diabres.2008.12.003_bib30","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/art.20040","article-title":"Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus","volume":"50","author":"Lin","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.diabres.2008.12.003_bib31","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ng1020","article-title":"A regulatory polymorphism in the PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans","volume":"32","author":"Prokunina","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.diabres.2008.12.003_bib32","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/sj.gene.6364119","article-title":"Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus","volume":"5","author":"Chong","year":"2004","journal-title":"Genes Immunol."},{"key":"10.1016\/j.diabres.2008.12.003_bib33","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/art.20966","article-title":"A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese","volume":"52","author":"Kong","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.diabres.2008.12.003_bib34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/ar2071","article-title":"Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population","author":"Lee","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.diabres.2008.12.003_bib35","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1399-0039.2003.00136.x","article-title":"Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes","volume":"62","author":"Nielsen","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.diabres.2008.12.003_bib36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00439-006-0309-8","article-title":"PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children","volume":"121","author":"Ni","year":"2007","journal-title":"Hum. Genet."},{"key":"10.1016\/j.diabres.2008.12.003_bib37","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.metabol.2007.01.021","article-title":"Trinucleotide repeats of programmed cell death-1 gene are associated with susceptibility to type 1 diabetes mellitus","volume":"56","author":"Hiromine","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.diabres.2008.12.003_bib38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2249.2007.03546.x","article-title":"Programmed death 1 ligands transfected dendritic cells loaded with glutamic acid decarboxylase 65 (GAD65) inhibits both alloresponse and the GAD65 reactive lymphocyte response","volume":"151","author":"He","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.diabres.2008.12.003_bib39","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/j.1464-5491.2007.02297.x","article-title":"No evidence of association of the PDCD1 gene with type 1 diabetes","volume":"24","author":"Asad","year":"2007","journal-title":"Diabet. Med."}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822708006049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822708006049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T13:59:25Z","timestamp":1545487165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822708006049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0168822708006049"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2008.12.003","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}